Robuta

https://www.research.vt.edu/impact-recognition/highly-cited-researchers.html Highly Cited Researchers | Research and Innovation | Virginia Tech Discover Virginia Tech's faculty recognized as Clarivate™ Highly Cited Researchers, reflecting their significant influence in various research fields. highly cited researchersvirginia techinnovation https://www.ece.uw.edu/spotlight/nathan-kutz-clarivate-2025/ Professor Nathan Kutz named to Clarivate’s Highly Cited Researchers list | UW Department of... highly cited researchers listuw departmentprofessornathannamed https://staff.sussex.ac.uk/news/article/66355-five-sussex-academics-among-world-s-most-highly-cited Five Sussex academics among world’s most highly cited : Staff Hub : University of Sussex The Clarivate Plc analytics company today (19 November) revealed its 2024 list of Highly Cited Researchers highly citedstaff hubuniversity offivesussex https://www.explorationpub.com/oep/index/58 Open Exploration Announces 2025 Highly Cited Paper Award and Best Young Researcher Paper Award Open Exploration Announces 2025 Highly Cited Paper Award and Best Young Researcher Paper Award open explorationhighly citedpaper awardbest youngannounces https://cos.northeastern.edu/four-northeastern-researchers-named-to-2020-list-of-highly-cited-researchers/ Four Northeastern Researchers Named to 2020 List of 'Highly Cited Researchers' - Northeastern... Jan 15, 2025 - Each year, the researchers most cited by their peers are recognized for their achievements in science. This year the College of Science has four faculty with... highly citedfournortheasternresearchersnamed https://www.tohoku.ac.jp/japanese/2025/11/award20251114-clarivate.html Highly Cited Researchers ... | 受賞 | 東北大学 -TOHOKU UNIVERSITY- クラリベイト・アナリティクスのHighly Cited Researchers 2025に、以下の本学関係者7名が選出されました。 Highly Cited Researchers(高被引用論文著者)... highly cited researcherstohoku university https://warwick.ac.uk/fac/sci/med/news/news/highlycited25/ Highly Cited Researchers at Warwick Medical School Three Warwick Medical School academics have been named in Clarivate’s Highly Cited Researcher List 2025. highly cited researchersmedical schoolwarwick https://www.pnnl.gov/publications/thirteen-researchers-pacific-northwest-national-laboratory-among-worlds-most-highly Thirteen Researchers from Pacific Northwest National Laboratory Among World’s Most Highly Cited |... From developing new energy storage materials to revealing patterns of Earth’s complex systems, studies led by PNNL researchers are recognized for their... pacific northwestnational laboratoryhighly citedthirteenresearchers https://www.dana-farber.org/newsroom/news-releases/2019/dana-farber-cancer-institute-researchers-among-highly-cited-researchers-according-to-2019-web-of-science-group-list Dana-Farber Cancer Institute researchers among highly cited researchers according to 2019 Web of... 23 Dana-Farber Cancer Institute Faculty listed on the 2019 Highly Cited Researchers list from Web of Science Group dana farber cancer institutehighly citedaccording toresearchersamong https://www.selleck.au/epigenetic-reader-domain.html BET inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au BET inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. bet inhibitorsmultiplepotenthighlyselective https://www.selleck.au/c-Met.html c-Met Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au c-Met inhibitors (inhibiting targets of signalling pathways) used for various assays; some have entered clinical trials, which would be new cancer therapies. cmetinhibitorsmultiplepotent https://www.selleckchem.com/hdac-inhibitors-activators.html HDAC Inhibitors | HDAC Activators: 90+Potent, Highly Selective & Cited | Selleckchem HDAC inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. hdac inhibitorsactivatorspotenthighlyselective https://www.selleck.co.uk/bcr-abl.html Bcr-Abl inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk Bcr-Abl inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. bcr https://www.selleck.au/bcr-abl.html Bcr-Abl inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Au Bcr-Abl inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. bcrablinhibitorsactivatorsmultiple https://www.selleckchem.com/p38-MAPK.html p38 MAPK Inhibitors | p38 MAPK Activators: 50+Potent, Highly Selective & Cited | Selleckchem p38 MAPK inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. p38 mapkinhibitorsactivatorspotenthighly https://www.selleck.au/Ras.html KRas inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au K-Ras antagonist | K-Ras inhibitor | K-Ras agonist | K-Ras activator kras inhibitorsmultiplepotenthighlyselective https://www.selleck.au/mdm2.html MDM2/MDMX Inhibitors/Antagonists | Multiple potent, highly selective & well-cited | Selleck.Au MDM2/MDMX antagonist |MDM2/MDMX inhibitor |MDM2/MDMX agonist | MDM2/MDMX activator mdm2inhibitorsantagonistsmultiplepotent https://www.selleck.co.uk/mTOR.html mTOR Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk mTOR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. mtor inhibitorsactivatorsmultiple https://www.selleckchem.com/ezh1_2.html EZH2 Inhibitors: 20+Potent, Highly Selective & Cited | Selleckchem EZH2 antagonist | EZH2 inhibitor | EZH2 agonist |EZH2 activator ezh2 inhibitorspotenthighlyselectivecited https://www.selleck.co.uk/PD-1-PD-L1.html PD-1/PD-L1 | Multiple potent, highly selective & well-cited | Selleck.Co.Uk PD-1/PD-L1 inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer... pdl1multiplepotenthighly https://www.selleckchem.com/VEGFR-PDGFR.html VEGFR Inhibitors: 100+Potent, Highly Selective & Cited | Selleckchem VEGFR inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. vegfr inhibitorspotenthighlyselectivecited https://www.selleck.co.uk/p53.html p53 inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk p53 inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. p53inhibitorsactivatorsmultiple https://www.selleck.au/EGFR(HER).html EGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au EGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. egfr inhibitorsmultiplepotenthighlyselective https://news.ucsc.edu/2025/11/clarivate-2025/ UC Santa Cruz is the top public research university in the world for highly cited researchers amid... Feb 27, 2026 - 25 UC Santa Cruz researchers earned a spot on the prestigious annual list. uc santa cruzhighly cited researchers https://www.selleck.co.uk/prmt.html PRMT Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk prmt inhibitorsmultiplepotenthighly https://www.selleck.co.uk/HIF.html HIF Inhibitors/Modulators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk HIF inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. hifinhibitorsmodulatorsmultiple https://www.selleck.au/histone-methyltransferase.html Histone Methyltransferase Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au Histone methyltransferase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. histoneinhibitorsmultiplepotenthighly https://www.selleck.au/Akt.html Akt Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Au Akt inhibitors (inhibiting targets of signalling pathways) used for various assays; some have entered clinical trials, which would be new cancer therapies. akt inhibitorsactivatorsmultiplepotenthighly https://www.selleckchem.com/ATM.html ATM/ATR Inhibitors: 30+Potent, Highly Selective & Cited | Selleckchem Our ATM/ATR inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. atmatrinhibitorspotenthighly https://www.selleck.au/csf-1r.html CSF-1R Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au CSF-1R inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. csf1rinhibitorsmultiplepotent https://www.selleckchem.com/pka.html PKA Inhibitors | PKA Activators: 10+Potent, Highly Selective & Cited | Selleckchem PKA inhibitors are available at Selleck. Check PKA signaling reviews and assay information. pka inhibitorsactivatorspotenthighlyselective https://www.selleck.co.uk/hydroxysteroid-dehydrogenase-hsd.html Dehydrogenase Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk Dehydrogenase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. dehydrogenase inhibitorsmultiplepotenthighlyselective https://www.selleck.co.uk/ferroptosis.html Ferroptosis Inhibitors/Inducers | Multiple potent, highly selective & well-cited | Selleck.Co.Uk Ferroptosis inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. ferroptosis inhibitorsmultiple https://www.selleck.au/VEGFR-PDGFR.html VEGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au VEGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. vegfr inhibitorsmultiplepotenthighlyselective https://www.selleckchem.com/Src-bcr-Abl.html Src Inhibitors: 50+Potent, Highly Selective & Cited | Selleckchem Src inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. src inhibitorspotenthighlyselectivecited https://www.selleck.co.uk/PKC.html PKC Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk Inhibitors targeting PKC are available at Selleck. Also check the Protein Kinase C pathway reviews and assay information pkc inhibitorsmultiplepotenthighly https://www.selleck.co.uk/csf-1r.html CSF-1R Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk CSF-1R inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. csf https://www.selleck.co.uk/nf-kb.html NF-κB Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk Inhibitors on NF-kB signaling are available at Selleck. Check the NF-kappaB signaling reviews and assay information. nfinhibitorsmultiplepotenthighly https://www.selleck.au/PARP.html PARP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au PARP inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. parp inhibitorsmultiplepotenthighlyselective https://www.selleck.co.uk/FGFR.html FGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk FGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. fgfr inhibitorsmultiplepotenthighly https://www.selleck.au/hdac-inhibitors-activators.html HDAC Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Au HDAC inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. hdac inhibitorsactivatorsmultiplepotenthighly https://www.prweb.com/releases/zocalo-health-receives-highly-competitive-path-cited-grant-by-california-department-of-health-care-services-302642015.html Zócalo Health Receives Highly Competitive PATH CITED Grant by California Department of Health Care... Dec 15, 2025 - /PRNewswire-PRWeb/ -- Zócalo Health, a community-based primary care provider dedicated to delivering culturally relevant care to underserved and... department ofhealthreceiveshighly https://www.selleck.co.uk/yap.html YAP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk YAP antagonist | YAP inhibitor | YAP agonist | YAP activator yap inhibitorsmultiplepotenthighly https://www.selleck.co.uk/PARP.html PARP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk PARP inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. parp inhibitorsmultiplepotenthighly https://www.selleck.co.uk/HSP-90.html HSP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk HSP (HSP90) inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer... hsp inhibitorsmultiplepotenthighly https://www.selleckchem.com/CDK.html CDK Inhibitors: 140+Potent, Highly Selective & Cited | Selleckchem CDK inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies. cdk inhibitorspotenthighlyselectivecited https://www.selleck.co.uk/histone-methyltransferase.html Histone Methyltransferase Inhibitors | Multiple potent, highly selective & well-cited |... Histone methyltransferase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies. histoneinhibitorsmultiplepotenthighly https://www.selleck.co.uk/STING.html STING Antagonist/Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk stingantagonistinhibitorsmultiple https://www.selleck.au/HSP-90.html HSP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au HSP (HSP90) inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer... hsp inhibitorsmultiplepotenthighlyselective https://www.selleck.co.uk/Ras.html KRas inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk K-Ras antagonist | K-Ras inhibitor | K-Ras agonist | K-Ras activator kras inhibitorsmultiplepotenthighly